Matches in SemOpenAlex for { <https://semopenalex.org/work/W4226269565> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W4226269565 endingPage "13" @default.
- W4226269565 startingPage "9" @default.
- W4226269565 abstract "Many psychotic patients are treated with antipsychotic medications during acute agitation and aggressive behavior episodes in an attempt to achieve a rapid calming effect. Those medications include olanzapine, zuclopenthixol acetate, and haloperidol intramuscular administration. This study compared the effectiveness of these injections in reducing the need for restraint during agitated-psychotic episodes that include aggression. Sociodemographical and clinical data were retrieved from the electronic medical records of 179 patients who needed rapid calming while hospitalized in a mental health center with acute psychosis. The treatments administered were olanzapine intramuscular, zuclopenthixol acetate intramuscular, and haloperidol intramuscular. The assessed outcomes were rate of restraint and violent behavior. Olanzapine was found significantly more effective in reducing the need for restraint compared to zuclopenthixol acetate. No significant differences were found between haloperidol and the other two with regard to restraint. Neither were other significant differences found between the groups with regard to violent or self-harming behaviors. No significant differences were found in the rate of violent behavior and antipsychotic dosage at discharge. In conclusion, in inpatients with acute agitated psychosis, olanzapine intramuscular shows better efficacy in reducing the need for restraint, at least as compared to zuclopenthixol acetate intramuscular." @default.
- W4226269565 created "2022-05-05" @default.
- W4226269565 creator A5018466206 @default.
- W4226269565 creator A5033831506 @default.
- W4226269565 creator A5041582193 @default.
- W4226269565 creator A5057943460 @default.
- W4226269565 creator A5072724808 @default.
- W4226269565 date "2021-11-25" @default.
- W4226269565 modified "2023-10-16" @default.
- W4226269565 title "Olanzapine intramuscular shows better efficacy than zuclopenthixol acetate intramuscular in reducing the need for restraint, but not in comparison to haloperidol intramuscular" @default.
- W4226269565 cites W1742370 @default.
- W4226269565 cites W2005263128 @default.
- W4226269565 cites W2009577021 @default.
- W4226269565 cites W2027198501 @default.
- W4226269565 cites W2034845725 @default.
- W4226269565 cites W2037172357 @default.
- W4226269565 cites W2064638737 @default.
- W4226269565 cites W2066977585 @default.
- W4226269565 cites W2073886704 @default.
- W4226269565 cites W2103338429 @default.
- W4226269565 cites W2157222287 @default.
- W4226269565 cites W2171532531 @default.
- W4226269565 cites W2507950479 @default.
- W4226269565 cites W2592634462 @default.
- W4226269565 cites W2885312069 @default.
- W4226269565 cites W3081915790 @default.
- W4226269565 cites W2021116631 @default.
- W4226269565 doi "https://doi.org/10.1097/yic.0000000000000381" @default.
- W4226269565 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34825897" @default.
- W4226269565 hasPublicationYear "2021" @default.
- W4226269565 type Work @default.
- W4226269565 citedByCount "0" @default.
- W4226269565 crossrefType "journal-article" @default.
- W4226269565 hasAuthorship W4226269565A5018466206 @default.
- W4226269565 hasAuthorship W4226269565A5033831506 @default.
- W4226269565 hasAuthorship W4226269565A5041582193 @default.
- W4226269565 hasAuthorship W4226269565A5057943460 @default.
- W4226269565 hasAuthorship W4226269565A5072724808 @default.
- W4226269565 hasConcept C118552586 @default.
- W4226269565 hasConcept C126322002 @default.
- W4226269565 hasConcept C15744967 @default.
- W4226269565 hasConcept C2776291583 @default.
- W4226269565 hasConcept C2776412080 @default.
- W4226269565 hasConcept C2776619155 @default.
- W4226269565 hasConcept C2779727114 @default.
- W4226269565 hasConcept C2780494398 @default.
- W4226269565 hasConcept C2780948584 @default.
- W4226269565 hasConcept C2781353949 @default.
- W4226269565 hasConcept C42219234 @default.
- W4226269565 hasConcept C513476851 @default.
- W4226269565 hasConcept C71924100 @default.
- W4226269565 hasConceptScore W4226269565C118552586 @default.
- W4226269565 hasConceptScore W4226269565C126322002 @default.
- W4226269565 hasConceptScore W4226269565C15744967 @default.
- W4226269565 hasConceptScore W4226269565C2776291583 @default.
- W4226269565 hasConceptScore W4226269565C2776412080 @default.
- W4226269565 hasConceptScore W4226269565C2776619155 @default.
- W4226269565 hasConceptScore W4226269565C2779727114 @default.
- W4226269565 hasConceptScore W4226269565C2780494398 @default.
- W4226269565 hasConceptScore W4226269565C2780948584 @default.
- W4226269565 hasConceptScore W4226269565C2781353949 @default.
- W4226269565 hasConceptScore W4226269565C42219234 @default.
- W4226269565 hasConceptScore W4226269565C513476851 @default.
- W4226269565 hasConceptScore W4226269565C71924100 @default.
- W4226269565 hasIssue "1" @default.
- W4226269565 hasLocation W42262695651 @default.
- W4226269565 hasLocation W42262695652 @default.
- W4226269565 hasOpenAccess W4226269565 @default.
- W4226269565 hasPrimaryLocation W42262695651 @default.
- W4226269565 hasRelatedWork W1711188166 @default.
- W4226269565 hasRelatedWork W1979518602 @default.
- W4226269565 hasRelatedWork W2025926616 @default.
- W4226269565 hasRelatedWork W2027198501 @default.
- W4226269565 hasRelatedWork W2034462924 @default.
- W4226269565 hasRelatedWork W2083311377 @default.
- W4226269565 hasRelatedWork W2147009310 @default.
- W4226269565 hasRelatedWork W2152031628 @default.
- W4226269565 hasRelatedWork W2171532531 @default.
- W4226269565 hasRelatedWork W4226269565 @default.
- W4226269565 hasVolume "37" @default.
- W4226269565 isParatext "false" @default.
- W4226269565 isRetracted "false" @default.
- W4226269565 workType "article" @default.